PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	2.59T -20.3%
Revenue (ttm)	9.22T -7.2%
Net Income	-334.96B
EPS	-60.17
Shares Out	5.57B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	638,100
Average Volume	300,685
Open	458.00
Previous Close	466.00
Day's Range	458.00 - 486.00
52-Week Range	410.00 - 765.00
Beta	1.22
RSI	56.76
Earnings Date	Jun 2, 2026

About PT Kimia Farma Tbk

PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as well as trades in and distributes drugs to pharmacies, hospital pharmacy installation, medical center, and drug store. In addition, it produces quinine sa...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 9,643
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2025, PT Kimia Farma Tbk's revenue was 9.22 trillion, a decrease of -7.20% compared to the previous year's 9.94 trillion. Losses were -334.96 billion, -60.23% less than in 2024.